Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
World Vitiligo Map
Your guide to the vitiligo community worldwide. Use the selector to filter by patient support groups, specialists, research centers, clinical trial locations, or World Vitiligo Day events.
Directory Information & Disclaimer
This free public directory gathers information from public sources to help connect our global community. Medical professionals and organizations listed are independent and not affiliated with or endorsed by the Vitiligo Research Foundation (VRF), and no fees are accepted for listings.
Because clinics, support groups, and specialists move or update their services over time, some information may occasionally become outdated. As a result, VRF cannot guarantee the complete accuracy or usefulness of listed third-party resources.
Help Us Keep the Map Accurate
Do you need to add a listing, update outdated details, or request a removal? Please reach out to us using the feedback form on our Contact Us page.
Search Map
78 records found for “NCT06804811” · show all
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Great Ormond Street Hospital For Children Nhs Foundation Trust, London, WC1N 3JH, United Kingdom
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Manor Hospital (Walsall) - Walsall Healthcare Nhs Trust, Walsall, WS2 9PS, United Kingdom
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Centro de Investigaciones Medicas Mar Del Plata, Mar del Plata, B7600FYK, Argentina
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Hospital Del Nino Jesus, San Miguel de Tucumán, 04000, Argentina
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Universite Catholique de Louvain (Ucl) - Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, 01200, Belgium
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Centre Hospitalier Victor Dupouy, Argenteuil, 95107, France
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Centre Hospitalier Universitaire de Nice,Hopital L Archet, Nice, 06200, France
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Centre Hospitalier Universitaire (Chu) de Toulouse - Hopital Larrey, Toulouse, 31059, France
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Katholisches Kinderkrankenhaus Wilhelmstift, Hamburg, 22149, Germany
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Debreceni Egyetem Klinikai Kozpon Belgyogy Klinika, Debrecen, 04032, Hungary
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11University of Pecs-Clinical Center, Pécs, 07632, Hungary
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11A.O. Policlinico Sant'Orsola Malpighi-Universita Degli Studi Di Bologna, Bologna, 40138, Italy
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Fondazione Policlinico Universitario Agostino Gemelli Irccs, Rome, 00137, Italy
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Centrum Badan Klinicznych Pi-House Sp. Z O.O., Gdansk, 80-546, Poland
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Hospital Geral de Santo Antonio, Porto, 4099-001, Portugal
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Hospital Universitario Fundacion Alcorcon, Alcorcón, 28922, Spain
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Hospital Infantil Unversitario Nino Jesus, Madrid, 28009, Spain
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Sheffield Childrens Hospital, Sheffield, S10 2TH, United Kingdom
1.855.463.3463
FAQOther Questions
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
- What causes vitiligo?
The exact cause is a complex puzzle, but we know the foundation: It is pre-wired in your genes. Think of your genetics as a loaded spring, just waiting for a specific "trigger" ...
- Diabetes and Vitiligo: Is There a Connection?
Yes, there appears to be a real connection between vitiligo and diabetes, especially type 1 diabetes. A recent study using UK Biobank data also found an association with type 2 ...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.